Aroa Biosurgery Limited
ASX:ARX.AX
0.56 (AUD) • At close November 5, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Aroa Biosurgery Limited |
Symbool | ARX.AX |
Munteenheid | AUD |
Prijs | 0.56 |
Beurswaarde | 193,144,000 |
Dividendpercentage | 0% |
52-weken bereik | 0.44 - 0.87 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Dr. Brian Ward |
Website | https://aroabio.com |
An error occurred while fetching data.
Over Aroa Biosurgery Limited
Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and distributing medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. The company's products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)